CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Plaque, Amyloid

Accumulations of extracellularly deposited AMYLOID FIBRILS within tissues.

Drugs by status

Phase 2 trials (2)

  • aci-24
  • lenalidomide

Other trials (1)

  • apolipoprotein

Organizations

Organization Involved with Phase 4 Indications (1)

  • Jiao Tong University

Organization Involved with Phase 3 Indications (1)

  • University of Lorraine

Organization Involved with Phase 2 Indications (5)

  • EIP Pharma, LLC
  • National Institute on Aging (NIA)
  • Chang Gung University
  • Free University of Amsterdam
  • The Cleveland Clinic

Organization Involved with Other Experimental Indications (13)

  • Centre Hospitalier Universitaire de Nīmes
  • University of Versailles
  • University of Utah
  • University of Toulouse
  • University of Montpellier
  • Centre Hospitalier Princesse Grace
  • University of Lyon
  • University of Reims
  • University of Paris
  • Aix-University of Marseille
  • University of Grenoble
  • University of Franche-Comté
  • University Clermont Auvergne

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.